Recrudescence of Helicobacter pylori after apparently successful eradication: Novel application of randomly amplified polymorphic DNA fingerprinting

Gut

Volumn 37, Issue 1, 1995, Pages 30-34

  Xia, H X ^a   Windle, H J ^b   Marshall, D G ^b   Smyth, C J ^b   Keane, C T ^a   O'Morain, C A ^b  

^a ST JAMES S HOSPITAL   (Ireland)

^b ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

DNA fingerprinting; Helicobacter pylori; Recrudescence

Indexed keywords

BISMUTH CITRATE; METRONIDAZOLE; TETRACYCLINE;

ADULT; AGED; ARTICLE; DNA FINGERPRINTING; DNA POLYMORPHISM; DUODENUM ULCER; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0028998922     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.37.1.30     Document Type: Article

References (32)

1. Patchett S, Beattie S, Leen E, Keane C, O'Morain C. Helicobacter pylori and duodenal ulcer recurrence. An J Gastroenterol 1992; 87: 24-7.
2. Rauws EA, Tytgat GNJ. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 335: 1233-5.
3. Forbes GM, Glaser ME, Cullen DJE, Warren JR, Christiansen KJ, Marshall BJ, et al. Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up. Lancet 1994; 343: 258-60.
4. Graham DY, Hepps KS, Ramirez FC, Lew GM, Saeed ZA. Treatment of Helicobacter pylori reduces the rebleeding in peptic ulcer disease. Scand J Gastroenterol 1993; 28: 939-42.
5. Labenz J, Borsch G. Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 1994; 55: 19-23.
6. Xia HX, Daw MA, Sam S, Beattie S, Keane CT, O'Morain CA. Clinical efficacy of triple therapy in Helicobacter pylori-associated duodenal ulcer. European Journal of Gastroenterology and Hepatology 1993; 5: 141-4.
7. Borody T, Andrews P, Mancuso N, Jankiewicz E, Brandi S. Helicobacter pylori reinfection 4 years post-treatment. Lancet 1992; 339: 1295.
8. Labenz J, Gyenes E, Ruhl GH, Borsch G. Helicobacter pylori re-infection and clinical course of peptic ulcer disease in the first year post-amoxicillin/omeprazole treatment. European Journal of Gastroenterology and Hepatology 1992; 4: 493-6.
9. Bell GD, Powell KU, Burridge SM, Harrison G, Rameh B, Weil J, et al. Reinfection or recrudescence after apparently successful eradication of Helicobacter pylori infection; implications for treatment of patients with duodenal ulcer disease. Q J Med 1993; 86: 375-82.
10. Xia HX, Gilvarry J, Sweeney EC, Beattie S, Hamilton H, Keane CT, et al. Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens. Am J Gastroenterol (in press).
11. Xia HX, English L, Keane CT, O'Morain CA. Enhanced cultivation of Helicobacter pylori in liquid media. J Clin Palhol 1993; 46: 750-3.
12. Markwell MAK, Haas SM, Bieberg LL, Tolbert NE. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 1978; 87: 206-10.
13. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
14. Majewski SI, Goodwin CS. Restriction endonuclease analysis of the genome of Campylobacter pylori with a rapid extraction method: evidence for considerable genomic variation. J Infect Dis 1988; 157: 465-71.
15. Mazurier S, van de Giessen A, Heuvelman K, Wernars K. RAPD analysis of Campylobacter isolates: DNA finger-printing without the need to purify DNA. Lett Appl Microbiol 1992; 14: 260-2.
16. Akopyanz N, Bukanov NO, Westblom TU, Kresovich S, Berg DE. DNA diversity among clinical isolates of Helicobacter pylori detected by PCR based RAPD finger-printing. Nucleic Acids Res 1992; 20: 5137-42.
17. Marshall DG, Chua A, Keeling PWN, Sullivan DJ, Coleman D, Smyth CJ. Molecular epidemiology of Helicobacter pylori isolates from gastric biopsies. Ir J Mid Sci 1993; 162: 514.
18. Costas M, Owen RJ, Bickley J, Morgan DR. Molecular techniques for studying the epidemiology of infection by Helicobacter pylori. Scand J Gastroenterol 1991; 26 (suppl 181): 20-32.
19. Langenberg W, Rauws EAJ, Widjojokusumo A, Tytgat GNJ, Zanen HC. Identification of Campylobacter pyloridis isolates by restriction endonuclease DNA analysis. J Clin Microbiol 1986; 24: 414-7.
20. Simor AE, Shames B, Drumm B, Sherman P, Low DE, Penner JL. Typing of Campylobacter pylori by bacterial DNA restriction endonuclease analysis and determination of plasmid profile. J Clin Microbiol 1990; 28: 83-6.
21. Tee W, Lambert J, Smallwood R, Schembri M, Ross BC, Dwyer B. Ribotyping of Helicobacter pylori from clinical specimens. J Clin Microbiol 1992; 30: 1562-7.
22. Owen RJ. Microbiological aspects of Helicobacter pylori infection. Communicable Disease Report Review 1993; 3: R51-6.
23. Welsh J, McClelland M. Fingerprinting genomes using PCR with arbitrary primers. Nucleic Acids Res 1990; 18: 7213-8.
24. Goodwin, Armstrong JA, Marshall BJ. Campylobacter pylori, gastritis and peptic ulcer. J Clin Pathol 1986; 39: 353-65.
25. Mai U, Geis G, Leying H, Ruhl G, Opferkuch W. Dimorphism of Campylobacter pylori. In: Megraud F, Lamouliatte H, eds. Gastroduodenal pathology and Campylobacter pylori. Amsterdam: Elsevier Science, 1989: 29-33.
26. Husson MO, Gottrand F, Turck D, Leclerc H. Detection of Helicobacter pylori in saliva using a monoclonal antibody. Int J Med Microbiol Virol Parasitol Infect Dis 1993; 279: 466-471.
27. Takagi A, Ohta U, Kohda K, Kobayashi H, Shirari T, Harasawa S, et al. Detection of Helicobacter pylori DNA in dental plaque by PCR [Abstract]. Am J Gastroenterol 1994; 89: 1298.
28. Thomas JE, Gibson GR, Darboe MK, Dale A, Weaver LT. Isolation of Helicobacter pylori from human faeces. Lancet 1992; 340: 1194-5.
29. Kelly SM, Pitcher MC, Farmery SM, Gibson GR. Isolation of Helicobacter pylori in faeces from patients in the UK - confirmation of culture identity by PCR [Abstract]. Gut 1994; 35 (suppl 2): S3.
30. Rauws EAJ, Langenberg W, Oudbier J, Mulder CJJ, Tytgat GNJ. Familial clustering of peptic ulcer disease colonized with C pylori of the same DNA composition. Gastroenterology 1989; 96: A409.
31. Xia HX, Keane CT, O'Morain CA. Pre-formed urease activity of Helicobacter pylori as determined by a viable cell count technique - clinical implications. J Med Microbiol 1994; 40: 435-9.
32. Nagata K, Satoh H, Iwahi T, Shimoyama T, Tamura T. Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H pylori cells. Antimicrob Agents Chemother 1993; 37: 769-74.